Shopping Cart
Remove All
Your shopping cart is currently empty
Inotuzumab Ozogamicin is an antibody-conjugated active molecule (ADC) that targets CD22 and is conjugated to Ozogamicin, a cytotoxic antibiotic. Inotuzumab Ozogamicin is indicated for use in the study of acute lymphoblastic leukemia (ALL).

| Description | Inotuzumab Ozogamicin is an antibody-conjugated active molecule (ADC) that targets CD22 and is conjugated to Ozogamicin, a cytotoxic antibiotic. Inotuzumab Ozogamicin is indicated for use in the study of acute lymphoblastic leukemia (ALL). |
| Synonyms | PF-5208773, PF-05208773, CMC-544 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Cas No. | 635715-01-4 |
| Relative Density. | no data available |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.